I remember reading this in January that someone had chosen Anavex as a stock of the year for 2020 (in January prior to the pandemic also prior to SAS and mostly based on the three CNS trials which were supposed to report in this year).
So, I really don’t know Bishop or his history or agenda, but if a guy wants cred in this field and followers (building a base as opposed to a one time head fake flip), people will remember what he stakes his rep on, imo.
He picked us as a stock of 2020 early in the year. If he makes good, it’s a lot like my program, you stand to gain credibility henceforth. If you don’t make a good call, but you make some money on a good flip, it better be substantial, because if your stock of the year ends up in the top 5 that’s very good! But if you pump the share price (where is that???) then screw the stock as soon as good/great appreciation takes hold and you turn your publicity against the stock - you have poisoned the well.
Would be a short lived profit as opposed to a career endeavor. In addition, I think that based on sentiment which favors our science, once this takes off, flipping back on it will not be profitable. Bigger firms such as Baker Bros who wouldn’t care to be outdone be the Fred Knoll’s of the world (brilliant move getting in early to indicate keen intuition - however, Bakers can demonstrate their savvy by getting in at the first sign of positive data, a good timing play). Both are savvy winners with different methods.
Tom would be up against it if his pick paid off and he flipped. Just an opinion, my opinion. FWIW.
Market Data 
Markets 
AI
